London Stock Exchange welcomes BiVictriX Therapeutics plc

London Stock Exchange today welcomes BiVictriX Therapeutics plc (“BiVictriX”), a rapidly emerging drug discovery and development company that begins trading on AIM under the ticker symbol BVX, following a successful initial public offering.

BiVictriX has successfully raised gross proceeds of £7.5 million by way of a placing and subscription at a market capitalisation of approximately £13.2 million. The funds will enable BiVictriX to accelerate its growth strategy and expedite the development and delivery of its next-generation, highly selective cancer therapeutics.

Founded by Tiffany Thorn in 2017, BiVictriX is applying a novel approach, derived from frontline clinical experience from within the NHS, to create safer, more effective cancer therapeutics. BiVictriX has developed a proprietary platform and the resulting Bi-Cygni® therapeutics are uniquely selective for the specific cancers, potentially enabling higher dosing and more aggressive tumour eradication, while reducing life-threatening treatment-related side effects.

Tiffany Thorn, Founder and CEO of BiVictriX, said: “Today’s listing on London’s AIM is a major milestone for BiVictriX. Our vision is to revolutionise cancer therapy for the most difficult to treat cancers, making curative treatments available to all. The funds raised will help us to accelerate our growth strategy and expedite the development and delivery of our pioneering, highly selective cancer therapeutics to patients diagnosed with some of the most challenging cancers. Supporting patients who are currently in urgent need of more effective medicines.

“I would like to take this opportunity to offer our sincere gratitude and thanks to all of our staff, advisers and shareholders who have been instrumental in getting us to where we are today. I would also like to take this opportunity to welcome new shareholders to the register and thank them for their support in enabling us to continue to carry out this critical work. I look forward to life as a public company and progressing our development programmes to the next stage with the support of our shareholders.”

Advisers to the IPO include:

  • SP Angel Corporate Finance LLP – Nominated Adviser and Broker
  • Acceleris Capital Limited – Financial Adviser
  • Slater Heelis Limited – Solicitors to BiVictriX
  • Gowlings WLG (UK) LLP – Solicitors to SP Angel
  • Crowe U.K. LLP – Reporting Accountant and Auditor
  • Consilium Strategic Communications – Financial Public Relations Adviser

Quick facts

Market: AIM
Instrument market cap (£m)
Listing/Admission to trading
11 Aug 2021
Looking for new and recent issues?

More recent

London Stock Exchange welcomes Softline to Main Market

London Stock Exchange today welcomes Softline, a leading global solutions and services provider in digital transformation and cybersecurity, to the Standard Segment of the Main Market of London Stock Exchange trading under the ticker symbol SFTL.

Softline's objective is to help improve business performance and quality of life through the most effective use o

Learn more
London Stock Exchange Welcomes Invesco celebrating the launch of Nasdaq-100 ESG UCITS ETF

Today, London Stock Exchange welcomes Invesco for the newest addition to the Invesco Nasdaq Innovation Suite, a new Environmental, Social and Governance (ESG) ETF: the Invesco Nasdaq-100 ESG UCITS ETF.

The Nasdaq-100 index has long been associated with growth and innovation, including many of today’s leading-edge companies, such as Apple, Amazon, Netflix and

Learn more
London Stock Exchange welcomes Tungsten West to AIM

Tungsten West Plc (“Tungsten West” or “the Company”) is a UK based company focussed on recommencing production at the Hemerdon tungsten and tin mine (“Hemerdon” or the “Project”) in Devon, England.

The Hemerdon mine is the world’s third largest Tungsten resource, had over £170m spent on it via the previous operator and has a mine life of 18.5 years. The Company is focused on rebuildin

Learn more
London Stock Exchange welcomes the Republic of Korea’s Sovereign Green Bond to the Sustainable Bond Market

London Stock Exchange today welcomes the Republic of Korea issuing their €700mn -0.053% note due October 2026 to London Stock Exchange’s International Securities Market. The deal was more than 6 times oversubscribed, receiving bids in excess of €4.2bn from over 150 accounts.

The €700mn 5-year tranche is Korea’s debut green bond and it was admitted yesterday to our Sustainable Bond Mar

Learn more